Late Effects of Childhood Cancer (Arnold Publication) PDF
Preview Late Effects of Childhood Cancer (Arnold Publication)
Late effects of childhood cancer This page intentionally left blank Late effects of childhood cancer Edited by W Hamish B Wallace MD FRCPCH Consultant Paediatric Oncologist, Department of Child Life and Health, Developmental and Reproductive Sciences, University of Edinburgh; and Department of Haematology/Oncology, Royal Hospital for Sick Children, Edinburgh and Daniel M Green MD Pediatric Oncologist, Department of Pediatrics, Roswell Park Cancer Institute, Buffalo, New York; and Professor of Pediatrics, Department of Pediatrics, School of Medicine and Biomedical Sciences, State University of New York, Buffalo, New York ARNOLD A member of the Hodder Headline Group LONDON First published in Great Britain in 2004 by Arnold, a member of the Hodder Headline Group, 338 Euston Road, London NW1 3BH http://www.arnoldpublishers.com Distributed in the United States of America by Oxford University Press Inc., 198 Madison Avenue, New York, NY10016 Oxford is a registered trademark of Oxford University Press © 2004 Arnold All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronically or mechanically, including photocopying, recording or any information storage or retrieval system, without either prior permission in writing from the publisher or a licence permitting restricted copying. In the United Kingdom such licences are issued by the Copyright Licensing Agency: 90 Tottenham Court Road, London W1T 4LP. Whilst the advice and information in this book are believed to be true and accurate at the date of going to press, neither the authors nor the publisher can accept any legal responsibility or liability for any errors or omissions that may be made. In particular (but without limiting the generality of the preceding disclaimer) every effort has been made to check drug dosages; however, it is still possible that errors have been missed. Furthermore, dosage schedules are constantly being revised and new side-effects recognized. For these reasons the reader is strongly urged to consult the drug companies' printed instructions before administering any of the drugs recommended in this book. British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library Library of Congress Cataloging-in-Publication Data A catalog record for this book is available from the Library of Congress ISBN 0 340 80803 9 1 23456789 10 Commissioning Editor: Joanna Koster Development Editor: Sarah Burrows Project Editor: Wendy Rooke Production Controller: Deborah Smith Cover Design: Lee-May Lim Typeset in 10/12 pt Minion by Charon Tec Pvt. Ltd, Chennai, India Printed in the UK by Butler ft Tanner Ltd. What do you think about this book? Or any other Arnold title? Please send your comments to [email protected] To Bill, Joan and Elizabeth HW To my wife, Lydia, and to our children Amy Lynn, Sarah Ann and Daniel Joseph DG This page intentionally left blank Contents Contributors ix Foreword xiii Reference annotation xv Colour plate section appears between pages 80 and 81 1 Introduction 1 W Hamish B Wallace and Daniel M Green 2 Neurological and special senses 3 2a Long-term neurologic consequences of CMS therapy 5 Patricia K Duffner 2b Neuropsychological outcomes 18 Raymond K Mulhern, Sean Phipps and Holly White 2c Ocular complications 37 Michael Ober, Katherine Beaverson and David Abramson 2d Hearing impairment 49 Patricia D Shearer 3 Secondary primary cancers 55 3a Epidemiology 57 Smita Bhatia 3b Genetic susceptibility and familial cancer syndromes 70 Manuel Diezi and David Malkin 4 Cardiovascular complications 83 4a Cardiotoxicity caused by chemotherapy 85 Andrea S Hinkle, Cindy B Proukou, Sampada S Deshpande, Sarah A Duffy, Amy M Kozlowski, Carol A French and Steven E Lipshultz 4b Radiation damage 101 Gill A Levitt and Frank H Saran 5 Respiratory complications 114 Neyssa Marina, Christine Sharisand Nancy Tarbell 6 Urological complications 123 6a Renal damage 125 Roderick Skinner 6b Bladder complications 138 R Beverly Raney, Robin Zagone and Michael Ritchey viii Contents 7 Gastrointestinal, hepatic and related complications 145 7a Body composition and obesity 147 John W Gregory and John J Reilly 7b The late effects of pediatric cancer treatment on the gastrointestinal tract 162 Nigel Meadows 7c Hepatic complications 170 Melissa M Hudson 7d Craniofacial development, teeth and salivary glands 176 Andrew LSonis 8 Endocrine and fertility effects 187 8a Growth and neuroendocrine consequences 189 Ken H Darzy, Helena K Gleeson and Stephen M Shalet 8b Disturbance of the hypothalmic-pituitary thyroid axis 212 Helena A Spoudeas 8c Ovarian and uterine function and reproductive potential 225 Hilary OD Critchley, Angela B Thomson and W Hamish B Wallace 8d Testicular function 239 Angela B Thomson, W Hamish B Wallace and Charles Sklar 8e Pregnancy outcome 257 Daniel M Green 9 Musculoskeletal complications 267 9a Osteoporosis 269 Bernadette MD Brennan 9b Bone and collagen turnover 279 Patricia M Crofton 9c Limb salvage and spinal surgery 293 Hannah Morgan and Ernest U Conrad III 10 Bone marrow transplantation 304 Roderick Skinner and Alison D Leiper 11 Cutaneous complications 321 E Claire Benton and Michael J Tidman 12 Quality of life issues 333 12a Quality of life and body image 335 Christine Eiser 12b Legal issues: US perspective 350 Grace-Ann P Monaco and Gilbert Smith 12c Legal issues: UK perspective 357 Alexander McCall Smith 13 Healthy lifestyle and prevention strategies 366 Melissa M Hudson 14 Strategy for long-term follow up 377 14a US perspective 379 Kevin C Oefflnger 14b UK perspective 392 Christopher JH Kelnar and W Hamish B Wallace Index 403 Contributors David Abramson MD Manuel Diezi MD Director, Robert M Ellsworth Ophthalmic Oncology Division of Hematology and Oncology, Hospital for Sick Center, Consultant, Memorial Sloan Kettering Cancer Children, Toronto, Ontario, Canada Institute, Weill Cornell Medical College, Patricia K Duffner MD New York-Presbyterian Hospital, New York, NY, USA Professor of Neurology and Pediatrics, State University of Katherine Beaverson MS New York at Buffalo, School of Medicine and Biomedical Weill Cornell Medical College, New York-Presbyterian Sciences, Children's Hospital of Buffalo, Buffalo, Hospital, Department of Ophthalmology, New York, NY, USA New York, USA E Claire Benton FRCP(Edm) Sarah A Duffy MS Consultant Dermatologist, Royal Infirmary of Edinburgh, Division of Pediatric Cardiology, Golisano Children's Edinburgh, UK Hospital at Strong and University of Rochester Medical Center, Rochester, New York Smita Bhatia MD MPH Director, Epidemiology and Outcomes Research, Division Christine Eiser PHD of Pediatric Hematology, Oncology and Bone Marrow Professor of Psychology, University of Sheffield, Transplantation, City of Hope National Medical Center, Sheffield, UK Duarte, CA, USA Carol A French MPH Bernadette MD Brennan MD FRCPCH Division of Pediatric Cardiology, Golisano Children's Consultant Paediatric Oncologist, Royal Manchester Hospital at Strong and University of Rochester Children's Hospital, Pendlebury, Manchester, UK Medical Center, Rochester, New York; and Ernest U Conrad III MD FACS Department of Pediatrics, University of Rochester Director, Pediatric Bone Tumor Clinic, Children's Hospital School of Medicine and Dentistry, Rochester, New York and Regional Medical Center, University of Washington, Helena K Gleeson Department of Orthopaedics and Sports Medicine, Clinical Research Fellow, Department of Endocrinology, Seattle, Washington, USA Christie Hospital, Withington, Manchester, UK Hilary OD Critchley MD FRCOG Daniel M Green MD Professor of Reproductive Medicine, Reproductive and Department of Pediatrics, Roswell Park Cancer Institute, Developmental Sciences, Centre for Reproductive Biology, Buffalo, New York; and Professor, University of Edinburgh, Edinburgh, UK Department of Pediatrics, School of Medicine and Patricia M Crofton Biomedical Sciences, University at Buffalo, Department of Paediatric Biochemistry, Royal Hospital State University of New York, Buffalo, for Sick Children, Edinburgh, UK New York, USA Ken H Darzy John W Gregory MD FRCP FRCPCH DCH MB CHB Lecturer in Medicine, Department of Endocrinology, Reader in Pediatric Endocrinology, Department of Diabetes and Metabolic Medicine, Queen Mary and Child Health, University of Wales College of Medicine, Westfield College, University of London, London, UK Cardiff, UK Sampada S Deshpande BS Andrea S Hinkle MD Division of Pediatric Cardiology, Golisano Children's Division of Hematology/Oncology, Golisano Children's Hospital at Strong and University of Rochester Medical Hospital at Strong and University of Rochester Medical Center, Rochester, New York Center, Rochester, New York; and
The list of books you might like
